Mukka Proteins reschedules investor meeting with Suraag Capital to Sep 29

scanx
Reviewed by
Shriram SScanX News Team
Key Highlights
  • Mukka Proteins rescheduled its virtual meeting with Suraag Capital to September 29, 2026
  • The meeting was originally scheduled for September 28, 2026
  • Disclosure made to NSE and BSE under Regulation 30 of SEBI LODR Regulations, 2015
  • No unpublished price sensitive information will be shared during the session
powered bylight_fuzz_icon
51787908

*this image is generated using AI for illustrative purposes only.

Mukka Proteins Limited has rescheduled its virtual analyst and institutional investor meeting with Suraag Capital to Tuesday, September 29, 2026. The interaction, originally slated for Monday, September 28, 2026, remains a one-on-one session allowing direct engagement between the company's management and the investment firm.

The company filed this intimation with the National Stock Exchange of India and BSE Limited pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The disclosure ensures transparency regarding the company's participation in investor conferences and meetings, noting that the schedule may undergo changes at the discretion of the analyst, institutional investor, or the company.

Meeting details and compliance

The updated schedule for the rescheduled meeting is as follows:

Original Date Rescheduled Date Name of Fund / Investor Venue / Mode Nature of Meeting
September 28, 2026 September 29, 2026 Suraag Capital Virtual Meeting One on One

Mukka Proteins stated that no unpublished price sensitive information pertaining to the company will be disclosed or shared during any of its meetings with analysts or institutional investors. The company emphasized that this rescheduling does not alter the nature of the engagement, which continues to be a direct dialogue format.

Investor resources

Stakeholders can access the latest investor presentation on the company's official website. The document provides updated information on the company's operations as a manufacturer and exporter of steam dried fish meal, fish oil, and fish soluble paste.

Historical Stock Returns for Mukka Proteins

1 Day5 Days1 Month6 Months1 Year5 Years
-0.22%-8.43%+1.69%+33.07%-1.67%-36.00%

How might the rescheduled dialogue with Suraag Capital influence Mukka Proteins' institutional investor base and future capital raising strategies?

What are the potential impacts of global seafood demand trends on Mukka Proteins' export revenues for fish meal and fish oil in the coming fiscal year?

Could the company's emphasis on compliance with SEBI Regulation 30 affect its valuation multiple relative to peers with less transparent investor engagement practices?

Mukka Proteins to hold virtual analyst meeting with IFC on Sep 25

scanx
Reviewed by
Jubin VScanX News Team
Key Highlights
  • Mukka Proteins Limited scheduled a virtual meeting with IFC for September 25, 2026
  • The interaction is a one-on-one analyst/institutional investor engagement
  • No unpublished price sensitive information will be shared during the meeting
  • Latest investor presentation is available on the company website
powered bylight_fuzz_icon
51635599

*this image is generated using AI for illustrative purposes only.

Mukka Proteins Limited will host a virtual one-on-one meeting with the International Finance Corporation (IFC) on September 25, 2026. The company confirmed the schedule in a filing to stock exchanges, marking an engagement with a major institutional investor.

Meeting Details

The interaction is classified as an analyst and institutional investor meeting. The company stated that no unpublished price sensitive information will be disclosed or shared during the session.

Day / Date Name of Fund / Investor Venue / Mode Nature of Meeting
Friday, September 25, 2026 International Finance Corporation (IFC) Virtual Meeting One on One

Regulatory Compliance and Resources

The intimation was issued pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company noted that the schedule may undergo changes at the discretion of the analyst, institutional investor, or the company.

Investors can access the latest investor presentation on the company's official website. The filing was signed by Mehaboobsab Mahmadoous Chalyal, Company Secretary & Compliance Officer.

Historical Stock Returns for Mukka Proteins

1 Day5 Days1 Month6 Months1 Year5 Years
-0.22%-8.43%+1.69%+33.07%-1.67%-36.00%

How might Mukka Proteins' engagement with the IFC influence its access to international capital markets or ESG-compliant financing in the coming fiscal year?

Could this meeting signal a potential equity stake or debt investment by the IFC, and what impact would such an entry have on Mukka Proteins' shareholding pattern?

What specific growth initiatives or expansion plans is Mukka Proteins likely highlighting to attract institutional interest from a development finance institution like the IFC?

More News on Mukka Proteins

1 Year Returns:-1.67%